Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-13
1993-09-21
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483024, A01N 4352, A61K 31415
Patent
active
052469557
ABSTRACT:
New cytotoxic quionones, designated amamitosenes and iminoazamitosenes are found to have significant activity against ovarian tumors, colon cancer, myecloma and the like neoplastic diseases.
Pharmaceutical preparations and therapeutic regimens utilizing azamitosenes and iminoazamitosenes and their pharmaceutically active derivatives are disclosed.
REFERENCES:
patent: 5015742 (1991-05-01), Skibo
Islam et al "Synthesis and Physical Studies of Azamitosene and Iminoazamitosene Reductive Alkylating Agents" J. Org. Chem. 1990, 55, 3195-3205.
Alberts David S.
Islam Imadul
Skibo Edward B.
Mybeck Richard R.
Nutter Nathan M.
Research Corporation Technologies Inc.
LandOfFree
Antineoplastic compounds and methods of using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antineoplastic compounds and methods of using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antineoplastic compounds and methods of using same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1050128